Correction to: Alpha-1 Antitrypsin Deficiency: a Rare Disease?
- PDF / 155,353 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 101 Downloads / 251 Views
CORRECTION
Correction to: Alpha-1 Antitrypsin Deficiency: a Rare Disease? Roxana Cortes-Lopez 1 & Igor Barjaktarevic 1
# Springer Science+Business Media, LLC, part of Springer Nature 2020
Correction to: Current Allergy Asthma Reports (2020) 20:51 https://doi.org/10.1007/s11882-020-00942-4 The original version of this article contained errors in Table 3 on page 6. In the last row, Trypsone was listed as a Grifols product in EU. This product has been discontinued. The corrected table is presented in this erratum.
Table 3
Available augmentation replacement therapies for alpha-1 antitrypsin deficiency
Product
Manufacturer
Prolastin C Prolastin C Liquid Glassia Aralast Zemaira Alfalastin
Grifols Grifols Takeda/Kamada Takeda CSL Behring Laboratoire français fractionnement et de Biotechnologies Respreeza CSL Behring Prolastin/Prolastina Grifols
Country
Formulation Dose
Dosing Concentration interval after reconsitution
Rate of infusion Duration of infusion
USA USA USA/Israel USA USA Frace
Lyophylized Liquid Liquid Lyophylized Lyophylized Lyophylized
Weekly Weekly Weekly Weekly Weekly Weekly
0.08 ml/kg/min 0.08 ml/kg/min 0.04 mL/kg/min 0.08 ml/kg/min 0.08 ml/kg/min 4 ml/mn
15 min 15 min 60–80 min 40 min 15 min 15 min
EU EU
Lyophylized 60 mg/Kg Weekly 50 mg/mL Lyophylized 60 mg/Kg Weekly 25 mg/mL
0.08 ml/kg/min 0.08 ml/kg/min
15 min 30 min
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/ 10.1007/s11882-020-00942-4 * Igor Barjaktarevic [email protected] 1
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, CHS, Los Angeles, CA 90095, USA
60 60 60 60 60 60
mg/Kg mg/Kg mg/Kg mg/Kg mg/Kg mg/Kg
50 50 20 20 50 50
mg/mL mg/mL mg/mL mg/mL mg/mL mg/mL
Data Loading...
